NASDAQ · Biotechnology

BioRestorative Therapies, Inc. (BRTX) Stock

$1.91 +1.06% NASDAQ: BRTX Healthcare

Valuation

MetricValue
Price$1.91
Market Cap$2.64M
P/E Ratio-0.10
P/B Ratio0.66
P/S Ratio8.64
EPS (TTM)$0.00
52-Week High$34.60
52-Week Low$1.87
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-423.84%
ROA-238.27%
ROCE-470.16%
Gross Margin0.00%
Operating Margin0.00%
Net Margin-30.90%
Debt/Equity0.01
Current Ratio0.75

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-26.0M$-19.0M$-15.0M$-12.0M$-16.0M
Net Profit$-44.0M$-13.0M$-10.0M$-9.0M$-14.0M
EPS$-746.00$-73.00$-49.40$-23.20$-31.60
Op Margin-57191.0%-15745.8%-10439.5%-2881.6%-4350.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$22.0M$16.0M$13.0M$12.0M$4.0M
Total Liabilities$1.0M$6.0M$3.0M$4.0M$4.0M
Cash$21.0M$2.0M$1.0M$1.0M$2.0M
Borrowings$1.0M$0$0$0$0

Latest News

BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform GlobeNewswire · Jun 25, 2026 BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth GlobeNewswire · Jun 18, 2026 BC-Most Active Stocks Associated Press · May 27, 2026 Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX) CNW Group · May 27, 2026 Sector Update: Healthcare Stocks Decline Tuesday Afternoon MT Newswires · May 26, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-3.0M$-6.0M$-6.0M$-8.0M$-11.0M
Investing Cash Flow$0$-14.0M$3.0M$0$9.0M
Financing Cash Flow$0$0$0$7.0M$0
Net Cash Flow$18.0M$-19.0M$-1.0M$0$1.0M
Free Cash Flow$-3.0M$-6.0M$-7.0M$-8.0M$-11.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA0.00
FCF Yield-384.57%
Quick Ratio2.35
Interest Coverage0.00
Return 1Y-77.92%
Return 3Y-89.60%
Return 5Y-98.30%

Ownership

Insiders Held12.13%
Institutions Held7.31%
Institutions Float Held8.32%
Institutional HolderSharesReport Date
Citadel Advisors Llc238,6062026-03-31
Geode Capital Management, LLC223,0832026-03-31
UBS Group AG99,8322026-03-31
Wealth Alliance, LLC40,0002026-03-31
Vanguard Fiduciary Trust Co39,4522026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BOLTBolt Biotherapeutics, Inc. $4.11 +12.60% -0.22 $7.90M 0.00%
COCPCocrystal Pharma, Inc. $1.07 +0.00% -1.49 $14.75M 0.00%
DWTXDogwood Therapeutics, Inc. $1.40 -0.71% -0.18 $47.08M 0.00%
EDSAEdesa Biotech, Inc. $3.51 -4.10% -2.28 $33.81M 0.00%
EVGNEvogene Ltd. $0.38 -4.09% -0.44 $3.29M 0.00%

About BioRestorative Therapies, Inc.

BioRestorative Therapies, Inc. is led by CEO Lance Alstodt, employs 11 people, headquartered in US, publicly traded since 2012.

BioRestorative Therapies, Inc. (BRTX) stock trades at $1.91 with a market capitalization of $2.64M. The stock is valued at a price-to-earnings (P/E) ratio of -0.10, price-to-book of 0.66, price-to-sales of 8.64. Over the past 52 weeks the stock has ranged between $1.87 and $34.60, and currently trades 94.5% below its 52-week high.

On profitability, BioRestorative Therapies, Inc. generates a return on equity (ROE) of -423.84%, return on capital employed of -470.16%, an operating margin of 0.00%, a net profit margin of -30.90%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides